Genelux Corporation (GNLX)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Diagnostic and Therapeutic Solutions	170.00K	Log In
Diagnostic and Therapeutic Solutions Growth	-98.46%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
United States	170.00K	Log In
United States Growth	-98.46%	Log In